Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.

about

Technical transformation of biodefense vaccines.The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.

P2860

Q37058898-6815D227-4FD9-4796-B3C3-1DD297C44CEB Q52573695-FB52608E-C8CC-418D-B374-22AAD5387E1C

P2860

Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.

Item

http://www.wikidata.org/entity/Q41183186

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Multiple gene expression in ba ...... African horsesickness disease.

@en

type

Item

label

Multiple gene expression in ba ...... African horsesickness disease.

@en

prefLabel

Multiple gene expression in ba ...... African horsesickness disease.

@en

P1476

Multiple gene expression in ba ...... African horsesickness disease.

@en

P2093

Roy P

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of bluetongue virus VP7

Bluetongue virus proteins.

Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells.

Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.

Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy.

Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.

Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

Structure of bluetongue virus particles by cryoelectron microscopy.

Protective efficacy of virus-like particles for bluetongue disease.

P304

318-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1996.TB53539.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

791

http://www.w3.org/2001/XMLSchema#string

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8784513

http://www.w3.org/2001/XMLSchema#string

Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.

about

P2860

P2860

Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698